The Art and Science of Managing Amyloidosis. Learn from expert physicians on the diagnosis and management of both AL and ATTR amyloidosis from our virtual event recorded on April 9, 2021. Earn CME/CNE credit through December 31, 2021.
Medscape is the leading online global destination for physicians and healthcare professionals worldwide with the latest medical news and expert perspectives; drug and disease information; and professional education and CME classes specific for amyloidosis.
AMYLOIDOSIS RESEARCH CONSORTIUM, INC. 320 Nevada Street, Suite 210 Newton, MA 02460 USA | 617-467-5170 firstname.lastname@example.org
ARC is a 501(c)(3) nonprofit organization. Tax ID: 47-2589708
Join our email list to stay up to date on the latest Amyloidosis news.
Boston University School of Medicine (BUSM) and the Amyloidosis Research Consortium (ARC) have partnered to provide an on-demand program where attendees will learn about amyloidosis care. This program is open to all specialties, but is primarily targeted to practicing physicians and nurses that most commonly see and treat amyloidosis patients.
This program will address the following gaps:
Clinicians need to better understand the presentation of amyloidosis symptoms and how to identify and diagnose possible amyloidosis patients.
Clinicians need to know what steps to take once they have identified a possible amyloidosis patient and who, how and when to refer.
Clinicians need to have current knowledge of treatments and the impact on progression of disease and survival.
Clinicians need to understand the important role of multidisciplinary teams in caring for patients with amyloidosis.
Led by an internationally renowned faculty team of amyloidosis experts, this program spotlights various aspects of the diagnosis, treatment and long-term management of amyloidosis. Attending clinicians will learn skills to identify, correctly diagnose, and treat amyloidosis patients in their clinical practice, as well as when and how to refer to specialty centers. The attendees will also learn about the value of multidisciplinary teams, and how to build an amyloidosis program to best support patients.
This program was recorded at a virtual meeting in April 2021. For ease of viewing, it has been split into four parts that can be taken independently.